全文获取类型
收费全文 | 21700篇 |
免费 | 1663篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 186篇 |
儿科学 | 455篇 |
妇产科学 | 439篇 |
基础医学 | 3019篇 |
口腔科学 | 575篇 |
临床医学 | 2304篇 |
内科学 | 4463篇 |
皮肤病学 | 352篇 |
神经病学 | 1965篇 |
特种医学 | 1212篇 |
外国民族医学 | 17篇 |
外科学 | 3259篇 |
综合类 | 160篇 |
一般理论 | 7篇 |
预防医学 | 1533篇 |
眼科学 | 357篇 |
药学 | 1380篇 |
中国医学 | 34篇 |
肿瘤学 | 1727篇 |
出版年
2023年 | 143篇 |
2022年 | 220篇 |
2021年 | 559篇 |
2020年 | 329篇 |
2019年 | 437篇 |
2018年 | 559篇 |
2017年 | 385篇 |
2016年 | 592篇 |
2015年 | 631篇 |
2014年 | 789篇 |
2013年 | 939篇 |
2012年 | 1392篇 |
2011年 | 1308篇 |
2010年 | 768篇 |
2009年 | 718篇 |
2008年 | 1147篇 |
2007年 | 1074篇 |
2006年 | 1014篇 |
2005年 | 965篇 |
2004年 | 872篇 |
2003年 | 867篇 |
2002年 | 743篇 |
2001年 | 541篇 |
2000年 | 569篇 |
1999年 | 519篇 |
1998年 | 220篇 |
1997年 | 184篇 |
1996年 | 158篇 |
1995年 | 145篇 |
1994年 | 124篇 |
1993年 | 121篇 |
1992年 | 363篇 |
1991年 | 317篇 |
1990年 | 297篇 |
1989年 | 263篇 |
1988年 | 274篇 |
1987年 | 231篇 |
1986年 | 261篇 |
1985年 | 235篇 |
1984年 | 192篇 |
1983年 | 178篇 |
1982年 | 97篇 |
1981年 | 97篇 |
1980年 | 99篇 |
1979年 | 153篇 |
1978年 | 114篇 |
1977年 | 98篇 |
1975年 | 89篇 |
1974年 | 106篇 |
1973年 | 118篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
13.
14.
15.
16.
Lesley A. Inker Morgan E. Grams Andrew S. Levey Josef Coresh Massimo Cirillo John F. Collins Ron T. Gansevoort Orlando M. Gutierrez Takayuki Hamano Gunnar H. Heine Shizukiyo Ishikawa Sun Ha Jee Florian Kronenberg Martin J. Landray Katsuyuki Miura Girish N. Nadkarni Carmen A. Peralta Dietrich Rothenbacher Mark Woodward 《American journal of kidney diseases》2019,73(2):206-217
17.
Erythropoietin(EPO) is one of the most successful biopharmaceuticals in history and is used for treating anemia of different origins. However, it became clear that EPO could also work in a neuroprotective, antiapoptotic, antioxidative, angiogenetic and neurotropic way. It causes stimulation of cells to delay cell apoptosis, especially in the central nervous system. In rodent models of focal cerebral ischemia, EPO showed an impressive reduction of infarct size by 30% and improvement of neurobehavioral outcome by nearly 40%. A large animal model dealing with ischemia and reperfusion of the spinal cord showed that EPO could reduce the risk of spinal cord injury significantly. In addition, some clinical studies tested whether EPO works in real live clinical settings. One of the most promising studies showed the innocuousness and improvements in follow-up, outcome scales and in infarct size, of EPO-use in humans suffering from ischemic stroke. Another study ended unfortunately in a negative outcome and an increased overall death rate in the EPO group. The most possible reason was the involvement of patients undergoing simultaneously systemic thrombolysis with recombinant tissue plasminogen activator. An experimental study on rats demonstrated that administration of EPO might exacerbate tissue plasminogen activator-induced brain hemorrhage without reducing the ischemic brain damage. This case shows clearly how useful animal models can be to check negative side effects of a treatment before going into clinical trials. Other groups looked in human trials at the effects of EPO on the outcome after ischemic stroke, relation to circulating endothelial progenitor cells, aneurysmal subarachnoid hemorrhage, traumatic brain injury, hemoglobin transfusion thresholds and elective first-time coronary artery bypass surgery. Most of the results were positive, but are based mostly on small group sizes. However, some of the most neglected facts when focusing on experimental setups of ischemia of the central nervous system are issues like age and comorbidities. It might be extremely worthy to consider these points for future projects, because EPO might influence all these factors. 相似文献
18.
19.
20.
Subdental synchondrosis and anatomy of the axis in aging: a histomorphometric study on 30 autopsy cases 总被引:4,自引:4,他引:0
Matthias Gebauer Christian Lohse Florian Barvencik Pia Pogoda Johannes M. Rueger Klaus Püschel Michael Amling 《European spine journal》2006,15(3):292-298
During skeletal development the two ossification centers of the odontoid process are separated from the corpus of the axis by a subdental synchondrosis. This synchondrosis is thought to close and disappear spontaneously in adolescence although this has never been studied in detail. The basis of the dens is of clinical relevance as type II dens fractures are located here. To characterize the morphological architecture of the axis with particular attention to the subdental synchondrosis, the complete axis was harvested from thirty age-matched and gender-matched patients of the three different age groups at autopsy. The subdental synchondrosis and the bone structure of the dens, the basis of the dens and the body of C2 were analyzed by radiography, histology and quantitative histomorphometry. At the macroscopic level the persistency of the subdental synchondrosis in the adult cervical spine was detected in 87% (26 of 30) of the specimens. Histomorphometry revealed a residual disc blastema with an average size of 25.8% of the sagittal depth of the basis of the dens at this level. Bony integration of the synchondrosis was poor throughout all ages. Histologically a cartilaginous matrix composition of the subdental synchondrosis persisted throughout all groups. The trabecular microarchitecture demonstrated a significant reduction of bone volume and trabecular number as well as an increased trabecular separation within the basis of the dens as compared to the corpus or the dens of C2. This histomorphometric data regarding a poor integration of the synchondrosis into the trabecular network and the reduced bone mass within the basis of the dens might offer a previously underestimated explanation for the occurrence of type II dens fractures and their association with pseudoarthrosis, respectively.Matthias Gebauer and Christian Lohse contributed equally to this study and therefore share first authorship. 相似文献